A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.Anthony Selwyn Stein, Mojca Jongen-Lavrencic,Sylvain Garciaz,Gerwin A. Huls,Abhishek Maiti,Nicolas Boissel,Stephane De Botton, Shaun Fleming,C. Michel Zwaan,David C. de Leeuw,Pinkal Desai,Martha Lucia Arellano,David Avigan, Saskia Langemeijer, Kyle A. Jensen, Timothy Wagenaar,Gu Mi, Giovanni Abbadessa,Ashish BajelJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
